Terminalia chebula Retz. As a resistance-modifying botanical drug against priority pathogens: a systematic review
Frontiers in Pharmacology · 09.06.2026 · 17
DOI: 10.3389/fphar.2026.1855899 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.06.2026. Verfasst von Kamran Zaman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Indian Council of Medical Research - National Institute of Traditional Medicine, Belagavi (ICMR-NITM Belagavi), Belagavi, Karnataka, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Background
The global rise of antimicrobial resistance (AMR) among priority bacterial pathogens represents a critical threat to public health, necessitating the development of alternative therapeutic strategies. Terminalia chebula Retz. ( Terminalia chebula ), a traditionally used medicinal plant rich in hydrolysable tannins, flavonoids, and polyphenolic metabolites, has emerged as a promising candidate due to its broad-spectrum antimicrobial and pharmacological properties.
Methods
This systematic review critically evaluates the in-vitro antimicrobial activity and resistance-modifying potential of T. chebula fruit extracts against ESKAPE pathogens, including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and Escherichia coli as a representative of the Enterobacteriaceae (now Enterobacterales) family. A comprehensive literature search was conducted across PubMed, Scopus, ScienceDirect, and Google Scholar databases in accordance with PRISMA guidelines and registered in PROSPERO (CRD420251024476). Based on predefined criteria, 24 studies were included for qualitative analysis.
Results
The findings demonstrate that T. chebula extracts exhibit in vitro antimicrobial activity, with ethanolic and methanolic extracts showing enhanced higher efficacy, particularly against multidrug-resistant strains of S. aureus , and P. aeruginosa , and E. coli . Notably, few studies reported synergistic interactions between phytochemicals and conventional antibiotics, suggesting antibiotic resistance-modifying roles. Mechanistic insights suggest that metabolites such as chebulagic acid, chebulinic acid, and gallic acid contribute to antimicrobial activity by disrupting the bacterial cell membranes, inhibiting biofilm formation, and interfering with resistance pathways. However, substantial variations in extraction methods and experimental designs limit cross-study comparability, highlighting the need for standardized protocols.
Conclusion
Overall, the evidence supports the potential of T. chebula act as a resistance-modifying and an antibiotic adjuvant. Future studies should prioritize bioassay-guided isolation, mechanistic validation, and preclinical evaluation to facilitate translational application in combating AMR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Indian Council of Medical Research - National Institute of Traditional Medicine, Belagavi (ICMR-NITM Belagavi), Belagavi, Karnataka, India.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Zaman, K., Ravedar, S., R, N., Karun, K., Patel, J., Felix, F., Akula, K. K., Hiremath, N., Tendulkar, S., Salunkhe, T., Kavathekar, A., & Bhat, J. (2026). Terminalia chebula Retz. As a resistance-modifying botanical drug against priority pathogens: a systematic review. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1855899
Vancouver
Zaman K, Ravedar S, R N, Karun K, Patel J, Felix F, et al. Terminalia chebula Retz. As a resistance-modifying botanical drug against priority pathogens: a systematic review. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1855899
BibTeX
@article{Zaman2026,
author = {Zaman, Kamran and Ravedar, Surthi and R, Nidhi and Karun, Kalesh and Patel, Jainabbi and Felix, Flemin and Akula, Kranthi Kiran and Hiremath, Nidhi and Tendulkar, Shivani and Salunkhe, Tejaswini and Kavathekar, Asif and Bhat, Jyothi},
title = {Terminalia chebula Retz. As a resistance-modifying botanical drug against priority pathogens: a systematic review},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1855899}
}
EUVIMED